ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
14.32
-0.70 (-4.66%)
At close: Mar 20, 2026, 4:00 PM EDT
14.69
+0.37 (2.59%)
After-hours: Mar 20, 2026, 7:59 PM EDT
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $3.41 billion as of March 20, 2026. Its market cap has decreased by -14.68% in one year.
Market Cap
3.41B
Enterprise Value
3.40B
1-Year Change
-14.68%
Ranking
Category
Stock Price
$14.32
Market Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $3.41B, an increase of 6,693.70%. That is a compound annual growth rate of 40.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.41B | -21.44% |
| Dec 31, 2025 | 4.34B | 7.08% |
| Dec 31, 2024 | 4.05B | 296.92% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
| Oct 17, 2013 | 50.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 3.72B |
| Corcept Therapeutics | 3.68B |
| Centessa Pharmaceuticals | 3.64B |
| ACADIA Pharmaceuticals | 3.54B |
| Dianthus Therapeutics | 3.46B |
| Structure Therapeutics | 3.44B |
| NewAmsterdam Pharma Company | 3.33B |
| Spyre Therapeutics | 3.24B |